Company Profile
Pulmonx Stock Price, News & Analysis
- Ticker:
- LUNG
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Pulmonx is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
1.28 USD (+0.79%)
Close
Last updated: June 23, 2026 at 00:00
54.06M USD
Market cap
Why the stock is moving
LUNG is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Pulmonx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Pulmonx is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Pulmonx follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Pulmonx sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Pulmonx to Participate in September Investor Conferences
Source: Pulmonx
- 03
- 04
Pulmonx Reports Third Quarter 2025 Financial Results
Source: Pulmonx
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Pulmonx (LUNG)?
Pulmonx (LUNG) most recently closed at 1.28 USD, a +0.79% move versus the previous session.
What is the market cap of Pulmonx (LUNG)?
Pulmonx currently has a market capitalization of 54.06M USD on BioPharmSignal.
What does Pulmonx do?
Pulmonx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is LUNG stock listed?
Pulmonx (LUNG) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Pulmonx is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Pulmonx?
Pulmonx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Pulmonx targeting with Pulmonx?
Pulmonx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.